{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:55:07Z","timestamp":1782604507094,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,22]]},"DOI":"10.7759\/cureus.35295","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T11:17:19Z","timestamp":1677064639000},"source":"Crossref","is-referenced-by-count":2,"title":["Radioactive Iodine-Induced Chronic Myeloid Leukemia in a Patient With Graves' Disease: A Case Report"],"prefix":"10.7759","author":[{"given":"Ahmed K","family":"Yasin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abu-Tineh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awni","family":"Alshurafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Abdulgayoom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Afana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Gameil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16599","article-title":"TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries","volume":"190","author":"Turkina A","year":"2020","unstructured":"Turkina A, Wang J, Mathews V, et al.. TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries. Br J Haematol. 2020, 190:869-76. 10.1111\/bjh.16599","journal-title":"Br J Haematol"},{"key":"ref2","article-title":"Gastrointestinal manifestations of CML: a systematic review","volume":"138","author":"Ali EA","year":"2021","unstructured":"Ali EA, Mushtaq K, Sardar S, Abdelmahmuod E, Yassin MA. Gastrointestinal manifestations of CML: a systematic review. Blood. 2021, 138:4609.","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5339\/connect.2014.24","article-title":"Molecular monitoring of patients with chronic myeloid leukemia (CML) in the state of Qatar: optimization of techniques and response to imatinib","volume":"2014","author":"Al-Dewik NI","year":"2014","unstructured":"Al-Dewik NI, Jewell AP, Yassin MA, El-Ayoubi HR, Morsi HM. Molecular monitoring of patients with chronic myeloid leukemia (CML) in the state of Qatar: optimization of techniques and response to imatinib. QSci Connect. 2014, 2014:24. 10.5339\/connect.2014.24","journal-title":"QSci Connect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-144807","article-title":"Chronic myeloid leukemia following exposure to radioactive iodine (I 131): a systematic review","volume":"138","author":"Hailan YM","year":"2021","unstructured":"Hailan YM, Yassin MA. Chronic myeloid leukemia following exposure to radioactive iodine (I 131): a systematic review. Blood. 2021, 138:4607-10. 10.1182\/blood-2021-144807","journal-title":"Blood"},{"key":"ref5","article-title":"","author":"Chennamadhavuni A","year":"2022","unstructured":"Chennamadhavuni A, Lyengar V, Mukkamalla SK, Shimanovsky A. Leukemia. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01841","article-title":"Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies","volume":"40","author":"Pasqual E","year":"2022","unstructured":"Pasqual E, Schonfeld S, Morton LM, Villoing D, Lee C, Berrington de Gonzalez A, Kitahara CM. Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies. J Clin Oncol. 2022, 40:1439-49. 10.1200\/JCO.21.01841","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3109\/10428199109068129","article-title":"Chronic myeloid leukemia following radioactive iodine (131)I therapy of thyroid cancer","volume":"5","author":"Hegde UP","year":"1991","unstructured":"Hegde UP, Gopal R, Nanjangud G, Advani SH. Chronic myeloid leukemia following radioactive iodine (131)I therapy of thyroid cancer. Leuk Lymphoma. 1991, 5:215-7. 10.3109\/10428199109068129","journal-title":"Leuk Lymphoma"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709059692","article-title":"Chronic myeloid leukemia in a woman with papillary carcinoma of the thyroid treated with radioactive iodine","volume":"27","author":"Alfiar F","year":"1997","unstructured":"Alfiar F, Amato D, Lipton JH. Chronic myeloid leukemia in a woman with papillary carcinoma of the thyroid treated with radioactive iodine. Leuk Lymphoma. 1997, 27:365-7. 10.3109\/10428199709059692","journal-title":"Leuk Lymphoma"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-015-0682-5","article-title":"Therapy-related acute myeloid leukemia following radioactive iodine treatment for thyroid cancer","volume":"27","author":"Oluwasanjo A","year":"2016","unstructured":"Oluwasanjo A, Pathak R, Ukaigwe A, Alese O. Therapy-related acute myeloid leukemia following radioactive iodine treatment for thyroid cancer. Cancer Causes Control. 2016, 27:143-6. 10.1007\/s10552-015-0682-5","journal-title":"Cancer Causes Control"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4137\/CMO.S32822","article-title":"Is adherence to imatinib mesylate treatment among patients with chronic myeloid leukemia associated with better clinical outcomes in Qatar?","volume":"10","author":"Al-Dewik NI","year":"2016","unstructured":"Al-Dewik NI, Morsi HM, Samara MM, et al.. Is adherence to imatinib mesylate treatment among patients with chronic myeloid leukemia associated with better clinical outcomes in Qatar?. Clin Med Insights Oncol. 2016, 10:95-104. 10.4137\/CMO.S32822","journal-title":"Clin Med Insights Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MD9.0000000000000061","article-title":"Dasatinib versus nilotinib as upfront therapy for treatment na\u00efve chronic myeloid leukemia chronic phase","volume":"2","author":"Yassin MA","year":"2021","unstructured":"Yassin MA, Hamad AA, Hussein RM, Basha AM, Adel AM, Chandra P, Nashwan AJ. Dasatinib versus nilotinib as upfront therapy for treatment na\u00efve chronic myeloid leukemia chronic phase. Med Case Rep Study Protoc. 2021, 2:e0061. 10.1097\/MD9.0000000000000061","journal-title":"Med Case Rep Study Protoc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/10732748211038429","article-title":"Clinicopathological variables and outcome in chronic myeloid leukemia associated with BCR-ABL1 transcript type and body weight: an outcome of European LeukemiaNet project","volume":"28","author":"Abdulla MA","year":"2021","unstructured":"Abdulla MA, Chandra P, Akiki SE, et al.. Clinicopathological variables and outcome in chronic myeloid leukemia associated with BCR-ABL1 transcript type and body weight: an outcome of European LeukemiaNet project. Cancer Control. 2021, 28:10732748211038429. 10.1177\/10732748211038429","journal-title":"Cancer Control"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3738","article-title":"How I treat obesity and obesity related surgery in patients with chronic myeloid leukemia: an outcome of an ELN project","volume":"9","author":"Yassin MA","year":"2021","unstructured":"Yassin MA, Kassem N, Ghassoub R. How I treat obesity and obesity related surgery in patients with chronic myeloid leukemia: an outcome of an ELN project. Clin Case Rep. 2021, 9:1228-34. 10.1002\/ccr3.3738","journal-title":"Clin Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/10732748211009256","article-title":"Effects of intermittent fasting on response to tyrosine kinase inhibitors (TKIs) in patients with chronic myeloid leukemia: an outcome of European LeukemiaNet project","volume":"28","author":"Yassin MA","year":"2021","unstructured":"Yassin MA, Ghasoub RS, Aldapt MB, et al.. Effects of intermittent fasting on response to tyrosine kinase inhibitors (TKIs) in patients with chronic myeloid leukemia: an outcome of European LeukemiaNet project. Cancer Control. 2021, 28:10732748211009256. 10.1177\/10732748211009256","journal-title":"Cancer Control"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1073274820976594","article-title":"Evaluation of hepatitis B reactivation among patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors","volume":"27","author":"Atteya A","year":"2020","unstructured":"Atteya A, Ahmad A, Daghstani D, Mushtaq K, Yassin MA. Evaluation of hepatitis B reactivation among patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. Cancer Control. 2020, 27:1073274820976594. 10.1177\/1073274820976594","journal-title":"Cancer Control"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-133904","article-title":"Association of tuberculosis in patients with chronic myeloid leukemia, a treatment proposal based on literature review","volume":"136","author":"Iqbal P","year":"2020","unstructured":"Iqbal P, Soliman AT, Desanctis V, Yassin MA. Association of tuberculosis in patients with chronic myeloid leukemia, a treatment proposal based on literature review. Blood. 2020, 136:28-9. 10.1182\/blood-2020-133904","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/139384-radioactive-iodine-induced-chronic-myeloid-leukemia-in-a-patient-with-graves-disease-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:51Z","timestamp":1707508191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/139384-radioactive-iodine-induced-chronic-myeloid-leukemia-in-a-patient-with-graves-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.35295","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,22]]}}}